QTMeds

Drug Database Monograph

TAKHZYRO 150 mg

PENDING REVIEW

Active Ingredient: LANADELUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 67650090

← Back to Prescription Analyzer